Healthcare / Health Information ServicesStockholm
$23.25
+0.10 (+0.43%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-5.2M · quality 51.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.6B
P/E
40.1x
↑EV/EBITDA
15.6x
↑ROE
4.3%
↑Gross Margin
84.1%
↑Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+18.3%
FCF CAGR
—
FCF margin
-0.1%
FCF / Net income
-0.01x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $343.8M · net income $34.7M · FCF $-476000.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $343.8M | $343.8M | $275.3M | $245.2M | $207.8M |
| Net Income | $34.7M | $34.7M | $-42.3M | $-46.7M | $33.2M |
| EBITDA | $96.4M | $96.4M | $17.5M | $2.9M | $73.7M |
| EPS | 0.50 | 0.50 | -0.58 | -0.60 | 0.42 |
| Gross Margin | 84.1% | 84.1% | 84.5% | 81.1% | 82.7% |
| Operating Margin | 2.7% | 2.7% | -18.0% | -15.4% | -0.7% |
| Net Margin | 10.1% | 10.1% | -15.4% | -19.0% | 16.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 |
| Current Ratio | 1.58 | 1.58 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-476000.00 | $-476000.00 | $-5.2M | $-73.6M | $-61.7M |
| Returns | |||||
| ROE | 4.3% | 4.3% | -4.7% | -4.9% | 2.6% |
| Valuation | |||||
| P/E | 40.09 | 40.09 | — | — | 39.94 |
| EV/EBITDA | 15.59 | 15.59 | 78.20 | 192.06 | 8.41 |
| P/B | 1.99 | 1.99 | 1.78 | 0.93 | 1.02 |
| Growth & Yield | |||||
| Revenue Growth | 24.9% | 24.9% | 12.3% | 18.0% | — |
| EPS Growth | 186.2% | 186.2% | 3.3% | -244.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
60.4%
EPS terminal req.
$2.06
Spread vs growth
125.8%
5Y implied EPS CAGR
37.9%
EPS terminal req.
$2.50
Spread vs growth
148.3%
10Y implied EPS CAGR
23.2%
EPS terminal req.
$4.02
Spread vs growth
163.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-7.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.58 → 0.50
Residual
-7.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.